Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of pulmonary rehabilitation programs and their effects on exercise capacity and health related quality of life (HRQoL) in patients with interstitial lung disease: A systematic review and meta-analysis.
Salazar JJ, Mirza FT, Uzzaman MN, Shunmugam RH, Shazana NZ, Pinnock H, Hirani N, Rabinovich RA. Salazar JJ, et al. Among authors: hirani n. Respir Med. 2025 Jan 4;237:107936. doi: 10.1016/j.rmed.2024.107936. Online ahead of print. Respir Med. 2025. PMID: 39756486 Free article. Review.
Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg).
Krauss E, Tello S, Naumann J, Wobisch S, Ruppert C, Kuhn S, Mahavadi P, Majeed RW, Bonniaud P, Molina-Molina M, Wells A, Hirani N, Vancheri C, Walsh S, Griese M, Crestani B, Guenther A; further eurILDreg investigators; RARE-ILD investigators. Krauss E, et al. Among authors: hirani n. BMC Pulm Med. 2024 Nov 18;24(1):572. doi: 10.1186/s12890-024-03389-9. BMC Pulm Med. 2024. PMID: 39558302 Free PMC article.
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease.
Cartlidge MK, Brown KK, Chaudhuri N, Corte TJ, Dieudé P, John L, Kelly C, Khanna D, McRorie E, Nicol L, Stewart G, Walsh SLF, Wijsenbeek M, Hirani N; PASSWRD participants. Cartlidge MK, et al. Among authors: hirani n. BMC Pulm Med. 2024 Oct 31;24(1):547. doi: 10.1186/s12890-024-03287-0. BMC Pulm Med. 2024. PMID: 39482644 Free PMC article.
Acute and chronic eosinophilic pneumonia: an overview.
Carbone RG, Puppo F, Mattar E, Roden AC, Hirani N. Carbone RG, et al. Among authors: hirani n. Front Med (Lausanne). 2024 Apr 22;11:1355247. doi: 10.3389/fmed.2024.1355247. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38711783 Free PMC article. Review.
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Frantz RP, McLaughlin VV, Sahay S, Escribano Subías P, Zolty RL, Benza RL, Channick RN, Chin KM, Hemnes AR, Howard LS, Sitbon O, Vachiéry JL, Zamanian RT, Cravets M, Roscigno RF, Mottola D, Osterhout R, Bruey JM, Elman E, Tompkins CA, Parsley E, Aranda R, Zisman LS, Ghofrani HA; TORREY Study Investigators. Frantz RP, et al. Lancet Respir Med. 2024 Jul;12(7):523-534. doi: 10.1016/S2213-2600(24)00072-9. Epub 2024 May 2. Lancet Respir Med. 2024. PMID: 38705167 Clinical Trial.
156 results